Myocarditis associated with primary amebic (Naegleria) meningoencephalitis.
D000293:Adolescent; D000328:Adult; D000656:Amoeba / Q000302:isolation & purification*; D000666:Amphotericin B / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D001996:Bronchopneumonia / Q000209:etiology; D002648:Child; D002738:Chloroquine / Q000627:therapeutic use; D004562:Electrocardiography; D004640:Emetine / Q000627:therapeutic use; D004804:Eosinophils; D005122:Exudates and Transudates / Q000473:pathology; D005260:Female; D006505:Hepatitis / Q000209:etiology; D006801:Humans; D008297:Male; D008590:Meningoencephalitis / Q000150:complications* / Q000188:drug therapy; D008795:Metronidazole / Q000627:therapeutic use; D009205:Myocarditis / Q000209:etiology*; D009206:Myocardium / Q000473:pathology; D010406:Penicillins / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000209:etiology; D013411:Sulfadiazine / Q000627:therapeutic use; D013444:Sulfisoxazole / Q000627:therapeutic use
D010406:Penicillins; D013411:Sulfadiazine; D008795:Metronidazole; D013444:Sulfisoxazole; D000666:Amphotericin B; D002738:Chloroquine; D004640:Emetine